Dear Colleagues,

Inherited aortic diseases are a group of genetic disorders that affect the structure and function of the aorta, the largest artery in the body. These conditions include Marfan syndrome, Ehlers–Danlos syndrome, Loeys–Dietz syndrome, and familial thoracic aortic aneurysm and dissection. The aorta may become weakened, leading to the formation of aneurysms or dissections, both of which can be life-threatening if left untreated. The genetic basis of these conditions is well established, with mutations in genes encoding extracellular matrix proteins, in addition to the emergence of signaling receptors, being the most common causes.

Advanced research into inherited aortic diseases has focused in recent years on developin a better understanding of the pathophysiology of these conditions, identifying novel genetic mutations, developing effective diagnostic tools, and improving treatment strategies. Recent advances in molecular genetics and next-generation sequencing technologies have led to the identification of new genes associated with inherited aortic diseases, as well as the development of targeted therapies. In addition, new imaging techniques, such as computed tomography angiography and magnetic resonance imaging, have enabled earlier detection of aortic aneurysms and dissections, important breakthroughs which may improve patient outcomes.

Despite these advances, much remains to be learned about the underlying mechanisms of inherited aortic diseases, particularly with regards to genotype–phenotype correlations and the role of environmental factors. Further research into this field may lead to improved diagnostic and treatment strategies, as well as a better understanding of the genetic basis of other cardiovascular diseases.

Dr. Wassim Mosleh
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cardiogenetics is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• aortic
• disease
• aorta
• inherited
• cardiogenetics
• aneurysm
• dissection pathophysiology
• diagnosis
• treatment